Bill Introduced to Authorize Medical Cannabis for Treatment of Sickle Cell Anemia

BACK TO INSIGHTS     Articles

January 31, 2023

Assembly Bill 4944, introduced in the New Jersey Assembly on December 8, 2022, would authorize the medical use of cannabis for the treatment of sickle cell anemia. The Bill states that the medical use of cannabis can treat or alleviate the pain or other symptoms associated with sickle cell anemia.

For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | jfanburg@bracheichler.com
Edward Hilzenrath | 973.403.3114 | ehilzenrath@bracheichler.com
Vanessa Coleman | 973.364.5208 | vcoleman@bracheichler.com

*This is intended to provide general information, not legal advice. Please contact the authors if you need specific advice.

Related Practices:   Healthcare Law